Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?

Clinical Nutrition

Volumn 31, Issue 1, 2012, Pages 85-88

  Scheede Bergdahl, Celena ^a,b   Watt, Heather L ^a   Trutschnigg, Barbara ^a   Kilgour, Robert D ^a,b   Haggarty, Allison ^c   Lucar, Enriqueta ^a   Vigano, Antonio ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b Gina Cody School of Engineering and Computer Science   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Advanced cancer patients; Cachexia; Clinical correlates; Cytokines

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; CACHEXIA; CANCER FATIGUE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GRIP STRENGTH; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; UPREGULATION; WEAKNESS; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; APPETITE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CACHEXIA; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SARCOPENIA; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 84856229722     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.07.010     Document Type: Article

References (10)

1. Bauer J., Capra S., Ferguson M. Use of the scored patient-generated subjective global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002, 56(8):779-785.
2. Baumgartner R.N. Body composition in healthy aging. Ann N Y Acad Sci 2000, 904:437-448.
3. Bruera E., Kuehn N., Miller M.J., Selmser P., Macmillan K. The edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. JPalliat Care 1991, 7(2):6-9.
4. Cohen S.R., Mount B.M., Strobel M.G., Bui F. The McGill quality of life questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 1995, 9(3):207-219.
5. Evans W.J., Morley J.E., Argilés J., Bales C., Baracos V., Guttridge D., et al. Cachexia: a new definition. Clin Nutr 2008, 27(6):793-799.
6. Fearon K., Strasser F., Anker S.D., Bosaeus I., Bruera E., Fainsinger R.L., et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011 Feb 4, [Epub ahead of print].
7. Mendoza T.R., Wang X.S., Cleeland C.S., Morrissey M., Johnson B.A., Wendt J.K., et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 1999, 85(5):1186-1196.
8. Motlotkov A., Satoh M., Tohyama C. Tumor growth and food intake in interleukin-6 gene knock-out mice. Cancer Lett 1998, 132(1-2):187-192.
9. Muscaritoli M., Anker S.D., Argilés J., Aversa Z., Bauer J.M., Biolo G., et al. Consensus definition of sarcopenia, cachexia and precachexia: joint document elaborated by special interest groups (SIG) " cachexia-anorexia in chronic wasting diseases" and " nutrition in geriatrics" Clin Nut 2010, 29(2):154-159.
10. Skogstrand K., Ekelund C.K., Thorsen P., Vogel I., Jacobsson B., Nørgaard-Pedersen B., et al. Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. JImmunol Methods 2008, 336(1):78-84.